Diet and Nutritional Interventions with the Special Role of Myo-Inositol in Gestational Diabetes Mellitus Management. An Evidence-Based Critical Appraisal

被引:9
作者
Reyes-Munoz, Enrique [1 ]
Di Guardo, Federica [2 ]
Ciebiera, Michal [3 ]
Kahramanoglu, Ilker [4 ]
Sathya-palan, Thozhukat [5 ]
Lin, Li-Te [6 ]
Shah, Mohsin [7 ]
Karaman, Erbil [8 ]
Fang, Shangrong [9 ]
Zito, Gabriella [10 ]
Noventa, Marco [11 ]
机构
[1] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Endocrinol, Mexico City, DF, Mexico
[2] Univ Catania, Dept Gen Surg & Med Surg Specialties, Via Santa Sofia 78, I-95123 Catania, Italy
[3] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 2, Warsaw, Poland
[4] Istanbul Univ, Cerrahpasa Fac Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Istanbul, Turkey
[5] Univ Hull, Dept Diabet & Endocrinol, Kingston Upon Hull, N Humberside, England
[6] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan
[7] Khyber Med Univ, Inst Basic Med Sci, Dept Physiol, Peshawar, Pakistan
[8] Yuzuncu Yil Univ, Dept Obstet & Gynecol, Med Fac, Van, Turkey
[9] Peking Univ, Dept Obstet & Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China
[10] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Dept Obstet & Gynecol, Trieste, Italy
[11] Univ Padua, Dept Woman & Child Hlth, Padua, Italy
关键词
Gestational diabetes mellitus; metabolic diseases; diet; nutrition; myo-inositol; prevention; management; WEIGHT-GAIN; INSULIN-RESISTANCE; FAMILY-HISTORY; POTENTIAL ROLE; OBESE WOMEN; PREGNANCY; RISK; DIAGNOSIS; SUPPLEMENTATION; PREVALENCE;
D O I
10.2174/1381612825666190722155512
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Gestational Diabetes Mellitus (GDM), defined as glucose intolerance with onset or first recognition during pregnancy, represents one of the most common maternal-fetal complications during pregnancy and it is associated with poor perinatal outcomes. To date, GDM is a rising condition over the last decades coinciding with the ongoing epidemic of obesity and Type 2 Diabetes Mellitus (T2DM). Objective: The aim of this review is to discuss the role of diet and nutritional interventions in preventing GDM with the explanation of the special role of myo-inositol (MI) in this matter. Methods: We performed an overview of the most recent literature data on the subject with particular attention to the effectiveness of diet and nutritional interventions in the prevention of GDM with the special role of MI. Results: Nutritional intervention and physical activity before and during pregnancy are mandatory in women affected by GDM. Moreover, the availability of insulin-sensitizers such as different forms of inositol has dramatically changed the scenario, allowing the treatment of several metabolic diseases, such as those related to glucose dysbalance. Although the optimal dose, frequency, and form of MI administration need to be further investigated, diet supplementation with MI appears to be an attractive alternative for the GDM prevention as well as for the reduction of GDM-related complications. Conclusions: More studies should be conducted to prove the most effective nutritional intervention in GDM. Regarding the potential effectiveness of MI, further evidence in multicenter, randomized controlled trials is needed to draw firm conclusions.
引用
收藏
页码:2467 / 2473
页数:7
相关论文
共 93 条
[1]   Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG [J].
Agarwal, M. M. ;
Dhatt, G. S. ;
Othman, Y. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (04) :544-549
[2]   Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018 [J].
不详 .
DIABETES CARE, 2018, 41 :S137-S143
[3]   Sociodemographic Correlates of the Increasing Trend in Prevalence of Gestational Diabetes Mellitus in a Large Population of Women Between 1995 and 2005 [J].
Anna, Vibeke ;
van der Ploeg, Hidde P. ;
Cheung, N. Wah ;
Huxley, Rachel R. ;
Bauman, Adrian E. .
DIABETES CARE, 2008, 31 (12) :2288-2293
[4]   Impact of Restricted Maternal Weight Gain on Fetal Growth and Perinatal Morbidity in Obese Women With Type 2 Diabetes [J].
Asbjornsdottir, Bjorg ;
Rasmussen, Signe S. ;
Kelstrup, Louise ;
Damm, Peter ;
Mathiesen, Elisabeth R. .
DIABETES CARE, 2013, 36 (05) :1102-1106
[5]   Modulation of adipokines and cytokines in gestational diabetes and macrosomia [J].
Ategbo, J. -M. ;
Grissa, O. ;
Yessoufou, A. ;
Hichami, A. ;
Dramane, K. L. ;
Moutairou, K. ;
Miled, A. ;
Grissa, A. ;
Jerbi, M. ;
Tabka, Z. ;
Khan, N. A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10) :4137-4143
[6]   Uncoupling Between Insulin and Release of a D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator of Insulin Action in Obese Women With Polycystic Ovary Syndrome [J].
Baillargeon, Jean-Patrice ;
Iuorno, Maria J. ;
Apridonidze, Teimuraz ;
Nestler, John E. .
METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (02) :127-135
[7]   Gestational diabetes mellitus: definition, aetiological and clinical aspects [J].
Baz, Baz ;
Riveline, Jean-Pierre ;
Gautier, Jean-Francois .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (02) :R43-R51
[8]  
Bijok J, 2014, GINEKOL POL, V85, P527
[9]   Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012 [J].
Billionnet, Cecile ;
Mitanchez, Delphine ;
Weill, Alain ;
Nizard, Jacky ;
Alla, Francois ;
Hartemann, Agnes ;
Jacqueminet, Sophie .
DIABETOLOGIA, 2017, 60 (04) :636-644
[10]  
Bloomgarden ZT, 2010, DIABETES CARE, V33, pE60, DOI [10.2337/dc10-zb05, 10.2337/dc10-zb02, 10.2337/dc10-zb07, 10.2337/dc10-zb03, 10.2337/dc10-zb09, 10.2337/dc10-zb08, 10.2337/dc10-zb01]